| 0009-0051 | PROVERA® (medroxyprogesterone acetate tablets, USP) | Pharmacia & Upjohn Company LLC | Pfizer Italia S.r.l. | Pfizer Inc |
| 0009-0051 | PROVERA® (medroxyprogesterone acetate tablets, USP) | Pharmacia & Upjohn Company LLC | Pfizer Italia S.r.l. |
| 0009-0051-01 | PROVERA® (medroxyprogesterone acetate tablets, USP) | Pharmacia & Upjohn Company LLC | Pfizer Italia S.r.l. | Pfizer Inc |
| 0009-0051-01 | PROVERA® (medroxyprogesterone acetate tablets, USP) | Pharmacia & Upjohn Company LLC | Pfizer Italia S.r.l. |
| 0009-0065 | PROVERA® (medroxyprogesterone acetate tablets, USP) | Pharmacia & Upjohn Company LLC | Pfizer Italia S.r.l. | Pfizer Inc |
| 0009-0065 | PROVERA® (medroxyprogesterone acetate tablets, USP) | Pharmacia & Upjohn Company LLC | Pfizer Italia S.r.l. |
| 0009-0065-01 | PROVERA® (medroxyprogesterone acetate tablets, USP) | Pharmacia & Upjohn Company LLC | Pfizer Italia S.r.l. | Pfizer Inc |
| 0009-0065-01 | PROVERA® (medroxyprogesterone acetate tablets, USP) | Pharmacia & Upjohn Company LLC | Pfizer Italia S.r.l. |
| 0009-0287 | PROVERA® (medroxyprogesterone acetate tablets, USP) | Pharmacia & Upjohn Company LLC | Pfizer Italia S.r.l. | Pfizer Inc |
| 0009-0287 | PROVERA® (medroxyprogesterone acetate tablets, USP) | Pharmacia & Upjohn Company LLC | Pfizer Italia S.r.l. |
| 0009-0287-01 | PROVERA® (medroxyprogesterone acetate tablets, USP) | Pharmacia & Upjohn Company LLC | Pfizer Italia S.r.l. | Pfizer Inc |
| 0009-0287-01 | PROVERA® (medroxyprogesterone acetate tablets, USP) | Pharmacia & Upjohn Company LLC | Pfizer Italia S.r.l. |
| 0009-0626-01 | Depo-Provera ® medroxyprogesterone acetate injectable suspension, USP | Physicians Total Care, Inc. |
| 0009-0746 | These highlights do not include all the information needed to use DEPO-PROVERA CI safely and effectively. See full prescribing information for DEPO-PROVERA CI. DEPO-PROVERA CI (medroxyprogesterone acetate) injectable suspension, for intramuscular use Initial U.S. Approval: 1959 | Pharmacia & Upjohn Company LLC | Pfizer Manufacturing Belgium NV |
| 0009-0746-30 | These highlights do not include all the information needed to use DEPO-PROVERA CI safely and effectively. See full prescribing information for DEPO-PROVERA CI. DEPO-PROVERA CI (medroxyprogesterone acetate) injectable suspension, for intramuscular use Initial U.S. Approval: 1959 | Pharmacia & Upjohn Company LLC | Pfizer Manufacturing Belgium NV |
| 0009-0746-35 | These highlights do not include all the information needed to use DEPO-PROVERA CI safely and effectively. See full prescribing information for DEPO-PROVERA CI. DEPO-PROVERA CI (medroxyprogesterone acetate) injectable suspension, for intramuscular use Initial U.S. Approval: 1959 | Pharmacia & Upjohn Company LLC | Pfizer Manufacturing Belgium NV |
| 0009-4709 | These highlights do not include all the information needed to use DEPO-SUBQ PROVERA 104 ® safely and effectively. See full prescribing information for DEPO-SUBQ PROVERA 104. DEPO-SUBQ PROVERA 104 (medroxyprogesterone acetate) injectable suspension, for subcutaneous use Initial U.S. Approval: 1959 | Pharmacia & Upjohn Company LLC | Pfizer Manufacturing Belgium NV |
| 0009-4709-13 | These highlights do not include all the information needed to use DEPO-SUBQ PROVERA 104 ® safely and effectively. See full prescribing information for DEPO-SUBQ PROVERA 104. DEPO-SUBQ PROVERA 104 (medroxyprogesterone acetate) injectable suspension, for subcutaneous use Initial U.S. Approval: 1959 | Pharmacia & Upjohn Company LLC | Pfizer Manufacturing Belgium NV |
| 0009-7376 | These highlights do not include all the information needed to use DEPO-PROVERA CI safely and effectively. See full prescribing information for DEPO-PROVERA CI. DEPO-PROVERA CI (medroxyprogesterone acetate) injectable suspension, for intramuscular use Initial U.S. Approval: 1959 | Pharmacia & Upjohn Company LLC | Pfizer Manufacturing Belgium NV |
| 0009-7376-11 | These highlights do not include all the information needed to use DEPO-PROVERA CI safely and effectively. See full prescribing information for DEPO-PROVERA CI. DEPO-PROVERA CI (medroxyprogesterone acetate) injectable suspension, for intramuscular use Initial U.S. Approval: 1959 | Pharmacia & Upjohn Company LLC | Pfizer Manufacturing Belgium NV |
| 0046-0875 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Physicians Total Care, Inc. |
| 0046-0975 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Physicians Total Care, Inc. |
| 0046-1105 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Canada ULC |
| 0046-1105 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Dispensing Solutions, Inc. | PSS World Medical, Inc. |
| 0046-1105 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Inc | Pfizer Canada ULC |
| 0046-1105 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Physicians Total Care, Inc. |
| 0046-1105-11 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Canada ULC |
| 0046-1105-11 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Inc | Pfizer Canada ULC |
| 0046-1106 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Canada ULC |
| 0046-1106 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Inc | Pfizer Canada ULC |
| 0046-1106 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Physicians Total Care, Inc. |
| 0046-1106-11 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Inc | Pfizer Canada ULC |
| 0046-1106-11 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Canada ULC |
| 0046-1107 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Inc | Pfizer Canada ULC |
| 0046-1107 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | A-S Medication Solutions |
| 0046-1107 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Canada ULC |
| 0046-1107 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Avera McKennan Hospital |
| 0046-1107 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Dispensing Solutions, Inc. | PSS World Medical, Inc. |
| 0046-1107-11 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Inc | Pfizer Canada ULC |
| 0046-1107-11 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Canada ULC |
| 0046-1108 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Inc | Pfizer Canada ULC |
| 0046-1108 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Canada ULC |
| 0046-1108-11 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Canada ULC |
| 0046-1108-11 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Inc | Pfizer Canada ULC |
| 0046-2575 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Canada ULC |
| 0046-2575 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Inc | Pfizer Canada ULC |
| 0046-2575-12 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Inc | Pfizer Canada ULC |
| 0046-2575-12 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Canada ULC |
| 0046-2579 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | Physicians Total Care, Inc. |
| 0548-5400 | These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION USP safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION USP. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959 | Amphastar Pharmaceuticals, Inc. |
| 0548-5400 | These highlights do not include all the information needed to use Medroxyprogesterone acetate Contraceptive Injection safely and effectively. See full prescribing information for Medroxyprogesterone acetate Contraceptive Injection. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959 | Amphastar Pharmaceuticals, Inc. |
| 0548-5400-00 | These highlights do not include all the information needed to use Medroxyprogesterone acetate Contraceptive Injection safely and effectively. See full prescribing information for Medroxyprogesterone acetate Contraceptive Injection. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959 | Amphastar Pharmaceuticals, Inc. |
| 0548-5400-00 | These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION USP safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION USP. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959 | Amphastar Pharmaceuticals, Inc. |
| 0548-5400-25 | These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION USP safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION USP. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959 | Amphastar Pharmaceuticals, Inc. |
| 0548-5400-25 | These highlights do not include all the information needed to use Medroxyprogesterone acetate Contraceptive Injection safely and effectively. See full prescribing information for Medroxyprogesterone acetate Contraceptive Injection. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959 | Amphastar Pharmaceuticals, Inc. |
| 0548-5410 | These highlights do not include all the information needed to use Medroxyprogesterone acetate Contraceptive Injection safely and effectively. See full prescribing information for Medroxyprogesterone acetate Contraceptive Injection. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959 | Amphastar Pharmaceuticals, Inc. |
| 0548-5410-00 | These highlights do not include all the information needed to use Medroxyprogesterone acetate Contraceptive Injection safely and effectively. See full prescribing information for Medroxyprogesterone acetate Contraceptive Injection. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959 | Amphastar Pharmaceuticals, Inc. |
| 0548-5410-25 | These highlights do not include all the information needed to use Medroxyprogesterone acetate Contraceptive Injection safely and effectively. See full prescribing information for Medroxyprogesterone acetate Contraceptive Injection. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959 | Amphastar Pharmaceuticals, Inc. |
| 0548-5701 | These highlights do not include all the information needed to use Medroxyprogesterone acetate Contraceptive Injection safely and effectively. See full prescribing information for Medroxyprogesterone acetate Contraceptive Injection. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959 | Amphastar Pharmaceuticals, Inc. |
| 0548-5701 | These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION USP safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION USP. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959 | Amphastar Pharmaceuticals, Inc. |
| 0548-5701-00 | These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION USP safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION USP. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959 | Amphastar Pharmaceuticals, Inc. |
| 0548-5701-00 | These highlights do not include all the information needed to use Medroxyprogesterone acetate Contraceptive Injection safely and effectively. See full prescribing information for Medroxyprogesterone acetate Contraceptive Injection. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959 | Amphastar Pharmaceuticals, Inc. |
| 0548-5711 | These highlights do not include all the information needed to use Medroxyprogesterone acetate Contraceptive Injection safely and effectively. See full prescribing information for Medroxyprogesterone acetate Contraceptive Injection. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959 | Amphastar Pharmaceuticals, Inc. |
| 0548-5711-00 | These highlights do not include all the information needed to use Medroxyprogesterone acetate Contraceptive Injection safely and effectively. See full prescribing information for Medroxyprogesterone acetate Contraceptive Injection. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959 | Amphastar Pharmaceuticals, Inc. |
| 0555-0779 | MedroxyPROGESTERone Acetate Tablets, USP | Bryant Ranch Prepack |
| 0555-0779 | MedroxyPROGESTERone Acetate Tablets, USP | PD-Rx Pharmaceuticals, Inc. |
| 0555-0779 | MedroxyPROGESTERone Acetate Tablets USP | American Health Packaging |
| 0555-0779 | MedroxyPROGESTERone Acetate Tablets, USP | Teva Pharmaceuticals USA, Inc. |
| 0555-0779 | MedroxyPROGESTERone Acetate Tablets, USP | Preferred Pharmaceuticals, Inc. | Preferred Pharmaceuticals, Inc |
| 0555-0779 | MedroxyPROGESTERone Acetate Tablets USP 8410521/1125 Rx only | American Health Packaging |
| 0555-0779 | MedroxyPROGESTERone Acetate Tablets USP | RPK Pharmaceuticals, Inc. |
| 0555-0779 | MedroxyPROGESTERone Acetate Tablets USP | Denton Pharma, Inc. dba Northwind Pharmaceuticals |
| 0555-0779 | RedPharm Drug, Inc. DailyMed label | RedPharm Drug, Inc. |
| 0555-0779 | MedroxyPROGESTERone Acetate Tablets USP | Proficient Rx LP |
| 0555-0779 | MedroxyPROGESTERone Acetate Tablets, USP | Northwind Health Company, LLC |
| 0555-0779 | MedroxyPROGESTERone Acetate Tablets USP | NuCare Pharmaceuticals,Inc. |
| 0555-0779 | Medroxyprogesterone Acetate Tablets USP | Aidarex Pharmaceuticals LLC |
| 0555-0779 | MEDROXYPROGESTERONE ACETATE TABLETS, USP | Rebel Distributors Corp. |
| 0555-0779 | Medroxyprogesterone Acetate Tablets USP | Blenheim Pharmacal, Inc. |
| 0555-0779 | MedroxyPROGESTERone Acetate Tablets, USP | A-S Medication Solutions |
| 0555-0779 | Medroxyprogesterone Acetate Tablets USP | ReadyMeds |
| 0555-0779 | MedroxyPROGESTERone Acetate Tablets, USP | Bryant Ranch Prepack |
| 0555-0779 | MedroxyPROGESTERone Acetate Tablets USP | PharmPak, Inc. |
| 0555-0779-02 | MedroxyPROGESTERone Acetate Tablets, USP | Teva Pharmaceuticals USA, Inc. |
| 0555-0779-04 | MedroxyPROGESTERone Acetate Tablets, USP | Teva Pharmaceuticals USA, Inc. |
| 0555-0872 | MedroxyPROGESTERone Acetate Tablets, USP | A-S Medication Solutions |
| 0555-0872 | MedroxyPROGESTERone Acetate Tablets, USP | PD-Rx Pharmaceuticals, Inc. |
| 0555-0872 | MedroxyPROGESTERone Acetate Tablets, USP | Teva Pharmaceuticals USA, Inc. |
| 0555-0872 | MedroxyPROGESTERone Acetate Tablets, USP | Bryant Ranch Prepack |
| 0555-0872 | MedroxyPROGESTERone Acetate Tablets, USP | REMEDYREPACK INC. |
| 0555-0872 | Medroxyprogesterone Acetate Tablets USP | ReadyMeds |
| 0555-0872 | MedroxyPROGESTERone Acetate Tablets, USP | Coupler LLC |
| 0555-0872 | Medroxyprogesterone Acetate Tablets USP | Aidarex Pharmaceuticals LLC |
| 0555-0872-02 | MedroxyPROGESTERone Acetate Tablets, USP | Teva Pharmaceuticals USA, Inc. |
| 0555-0872-04 | MedroxyPROGESTERone Acetate Tablets, USP | Teva Pharmaceuticals USA, Inc. |
| 0555-0873 | Medroxyprogesterone Acetate Tablets USP | Dispensing Solutions, Inc. | PSS World Medical, Inc. |
| 0555-0873 | MedroxyPROGESTERone Acetate Tablets, USP | Preferred Pharmaceuticals Inc. |
| 0555-0873 | MedroxyPROGESTERone Acetate Tablets, USP | Teva Pharmaceuticals USA, Inc. |
| 0555-0873 | Medroxyprogesterone Acetate Tablets USP | Blenheim Pharmacal, Inc. |
| 0555-0873 | Medroxyprogesterone Acetate Tablets USP | Aidarex Pharmaceuticals LLC |
| 0555-0873 | MedroxyPROGESTERone Acetate Tablets, USP | A-S Medication Solutions |
| 0555-0873 | MedroxyPROGESTERone Acetate Tablets, USP | Bryant Ranch Prepack |
| 0555-0873-02 | MedroxyPROGESTERone Acetate Tablets, USP | Teva Pharmaceuticals USA, Inc. |
| 0555-0873-04 | MedroxyPROGESTERone Acetate Tablets, USP | Teva Pharmaceuticals USA, Inc. |
| 10544-001 | Medroxyprogesterone Acetate Tablets USP | Blenheim Pharmacal, Inc. |
| 10544-001-30 | Medroxyprogesterone Acetate Tablets USP | Blenheim Pharmacal, Inc. |
| 10544-062 | Medroxyprogesterone Acetate Tablets USP | Blenheim Pharmacal, Inc. |
| 10544-062-10 | Medroxyprogesterone Acetate Tablets USP | Blenheim Pharmacal, Inc. |
| 21695-896 | MEDROXYPROGESTERONE ACETATE TABLETS, USP | Rebel Distributors Corp. |
| 21695-896-10 | MEDROXYPROGESTERONE ACETATE TABLETS, USP | Rebel Distributors Corp. |
| 21695-896-20 | MEDROXYPROGESTERONE ACETATE TABLETS, USP | Rebel Distributors Corp. |
| 21695-896-30 | MEDROXYPROGESTERONE ACETATE TABLETS, USP | Rebel Distributors Corp. |
| 24201-150 | These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959 | Hikma Pharmaceuticals USA Inc. |
| 24201-150-00 | These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959 | Hikma Pharmaceuticals USA Inc. |
| 24201-150-01 | These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959 | Hikma Pharmaceuticals USA Inc. |
| 24201-150-25 | These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959 | Hikma Pharmaceuticals USA Inc. |
| 33261-534 | Medroxyprogesterone Acetate Tablets USP | Aidarex Pharmaceuticals LLC |
| 33261-534-05 | Medroxyprogesterone Acetate Tablets USP | Aidarex Pharmaceuticals LLC |
| 33261-534-10 | Medroxyprogesterone Acetate Tablets USP | Aidarex Pharmaceuticals LLC |
| 33261-534-14 | Medroxyprogesterone Acetate Tablets USP | Aidarex Pharmaceuticals LLC |